½ÃÀ庸°í¼­
»óǰÄÚµå
1659393

¼¼°èÀÇ ¹é½Å Àü´Þ µð¹ÙÀ̽º ½ÃÀå

Vaccine Delivery Devices

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Industry Analysts, Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 93 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¹é½Å Àü´Þ µð¹ÙÀ̽º ½ÃÀåÀº 2030³â±îÁö 66¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 51¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ¹é½Å Àü´Þ µð¹ÙÀ̽º ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 4.4%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 66¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ÁÖ»ç±â´Â CAGR 4.4%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á±îÁö 53¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¦Æ® ºÐ»ç±â ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 4.8%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 14¾ï ´Þ·¯, Áß±¹Àº CAGR 7.5%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¹é½Å Àü´Þ µð¹ÙÀ̽º ½ÃÀåÀº 2024³â¿¡ 14¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 14¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 7.5%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 1.2%¿Í 5.0%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è ¹é½Å Àü´Þ µð¹ÙÀ̽º ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

¹é½Å Àü´Þ µð¹ÙÀ̽º¶õ ¹«¾ùÀ̸ç, ¿Ö Çö´ë ¿¹¹æÁ¢Á¾¿¡ ÇʼöÀûÀΰ¡?

¹é½Å Àü´Þ µð¹ÙÀ̽º´Â ¹é½ÅÀ» ¾ÈÀüÇϰí, È¿°úÀûÀ̰í, Á¤È®ÇÏ°Ô Åõ¿©Çϱâ À§ÇØ °í¾ÈµÈ Ư¼öÇÑ Åø³ª ±â¼úÀ» ¸»ÇÕ´Ï´Ù. ÁÖ»ç±â, ¹«Ä§ÁÖ»ç±â, ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡, ºñ°­ÁÖ»ç±â, Çdz»ÁÖ»ç±â, °æ±¸Åõ¿©±â µîÀÌ Æ÷ÇԵ˴ϴÙ. ºÒȰȭ ¹é½Å, ¾àµ¶È­ ¹é½Å, mRNA ¹é½Å, ¾Æ´ÜÀ§ ¹é½Å, ¹ÙÀÌ·¯½º º¤ÅÍ ¹é½ÅÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ À¯ÇüÀÇ ¹é½ÅÀ» Àü´ÞÇϴµ¥ »ç¿ëµÇ¸ç, ÃÖÀûÀÇ ¸é¿ª¹ÝÀÀÀ» ¾ò±â À§ÇØ ¹é½ÅÀÌ ÀûÀýÇÑ Á¶Á÷¿¡ µµ´ÞÇϵµ·Ï ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â ¹é½Å Åõ¿©ÀÇ È¿À²¼º°ú Á¤È®¼ºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó ȯÀÚÀÇ ¼øÀÀµµ¸¦ ³ôÀ̰í, ÁÖ»çħ ¼Õ»ó À§ÇèÀ» ÁÙÀ̸ç, ³¶ºñ¸¦ ÃÖ¼ÒÈ­ÇÕ´Ï´Ù.

¹é½Å Àü´Þ µð¹ÙÀ̽ºÀÇ Á߿伺Àº ¾ÈÀüÇϰí È¿°úÀûÀÎ ¹é½Å Åõ¿©¸¦ º¸ÀåÇÔÀ¸·Î½á ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥ÀÇ ¼º°øÀ» Áö¿øÇÏ´Â ´É·Â¿¡ ÀÖ½À´Ï´Ù. È¿À²ÀûÀÎ ¹é½Å Åõ¿©´Â ³ôÀº ¿¹¹æÁ¢Á¾·üÀ» ´Þ¼ºÇϱâ À§ÇØ ÇʼöÀûÀ̸ç, ƯÈ÷ Áý´Ü ¿¹¹æÁ¢Á¾ Ä·ÆäÀÎÀ̳ª °¨¿°º´À» ÅëÁ¦Çϱâ À§ÇÑ °øÁߺ¸°Ç ³ë·Â¿¡ À־´Â ´õ¿í ±×·¯ÇÕ´Ï´Ù. ÀÚµ¿ ºñȰ¼ºÈ­ ÁÖ»ç±â¿Í °°Àº Àåºñ´Â Àç»ç¿ëÀ» ¹æÁöÇÏ°í °¨¿° À§ÇèÀ» ÁÙÀÌ´Â µ¥ µµ¿òÀÌ µÇ¸ç, ¹Ù´ÃÀ» »ç¿ëÇÏÁö ¾Ê´Â ÁÖ»ç±â´Â ¹Ù´Ã °øÆ÷ÁõÀ» °¡Áø »ç¶÷µéÀÇ ¹é½Å ¼ö¿ë¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ƯÈ÷ Àü¿°º´, Á¤±â ¿¹¹æÁ¢Á¾, ½ÅÁ¾ °¨¿°º´ ´ëÀÀ µî Àü ¼¼°è¿¡¼­ ¹é½Å Á¢Á¾¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¹é½Å Àü´Þ µð¹ÙÀ̽º´Â Àû½Ã¿¡ È¿°úÀûÀÎ ¿¹¹æÁ¢Á¾ Ȱµ¿À» Áö¿øÇÏ´Â ÀÇ·á ÀÎÇÁ¶óÀÇ Çʼö ¿ä¼Ò·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¹é½Å Àü´Þ µð¹ÙÀ̽º ½ÃÀåÀ» ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

±â¼úÀÇ ¹ßÀüÀ¸·Î ¹é½Å Àü´Þ µð¹ÙÀ̽ºÀÇ ¼³°è, ¾ÈÀü¼º ¹× È¿À²¼ºÀÌ Å©°Ô Çâ»óµÇ¾î Àü ¼¼°è ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥ÀÇ Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä °³¹ß Áß Çϳª´Â ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡ÀÇ µµÀÔÀ¸·Î, ÅëÁõ ¾øÀÌ ÇǺΠ³»·Î ¹é½ÅÀ» Åõ¿©ÇÒ ¼ö ÀÖ´Â ÃÖ¼Ò Ä§½ÀÀû ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡´Â ¹é½ÅÀ¸·Î ÄÚÆÃµÇ°Å³ª ä¿öÁ® ÀÖ°í ÀÚ°¡ Åõ¿©°¡ °¡´ÉÇϹǷΠÁý´Ü ¿¹¹æÁ¢Á¾ Ä·ÆäÀÎÀ̳ª ¿Üµý Áö¿ª, ÀÚ¿øÀÌ ºÎÁ·ÇÑ È¯°æ¿¡ ÀÌ»óÀûÀÔ´Ï´Ù. ÀÌ ÆÐÄ¡´Â ³ÃÀå º¸°üÀÌ ÇÊ¿äÇÏÁö ¾Ê±â ¶§¹®¿¡ ÄݵåüÀÎ ¹°·ù¸¦ ÁÙÀ̰í, ƯÈ÷ °³¹ßµµ»ó±¹¿¡¼­ ¹é½Å¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ Á¢±ÙÀ» ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù.

¶Ç ´Ù¸¥ ÁÖ¿ä ¹ßÀüÀº ¹Ù´Ã ¾ø´Â ÁÖ»ç±â °³¹ßÀÔ´Ï´Ù. ÀÌ ÁÖ»ç±â´Â °í¾ÐÀÇ È帧À» ÀÌ¿ëÇÏ¿© ¹Ù´ÃÀ» »ç¿ëÇÏÁö ¾Ê°í ÇǺθ¦ ÅëÇØ ¹é½ÅÀ» Åõ¿©ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â ¹Ù´Ã¿¡ Âñ¸®´Â ºÎ»óÀÇ À§ÇèÀ» ÁÙÀ̰í, ȯÀÚÀÇ ¼øÀÀµµ¸¦ ³ôÀ̸ç, »ý¹°ÇÐÀû À¯ÇØ Æó±â¹°À» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù. ¹«Ä§ ÁÖ»ç±â´Â µ¶°¨, È«¿ª, È«¿ª, °£¿° µîÀÇ ¹é½Å Á¢Á¾¿¡ »ç¿ëµÇ°í ÀÖÀ¸¸ç, COVID-19 ¹× °áÇÙ°ú °°Àº »õ·Î¿î ¹é½Å¿¡µµ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ÁÖ»ç¹Ù´ÃÀ» »ç¿ëÇÏÁö ¾Ê´Â ½Ã½ºÅÛ°ú ´õºÒ¾î ÀÚµ¿ °³Æó½Ä ÁÖ»ç±âÀÇ ±â¼ú Çõ½ÅÀ¸·Î ¿¹¹æÁ¢Á¾½Ã ¾ÈÀü¼ºÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ÀÌ ÁÖ»ç±â´Â ÇÑ ¹ø »ç¿ëÇϸé ÀÚµ¿À¸·Î Àá±âµµ·Ï ¼³°èµÇ¾î Àç»ç¿ëÀ» ¹æÁöÇÏ°í ±³Â÷ ¿À¿°ÀÇ À§ÇèÀ» ÁÙÀ̱â À§ÇØ Æ¯È÷ Áý´Ü Ä·ÆäÀο¡¼­ ¾ÈÀüÇÑ ¹é½Å Á¢Á¾¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù.

µðÁöÅÐ ±â¼úÀ» ÅëÇÕÇÑ ½º¸¶Æ® Àü´Þ ÀåºñÀÇ µîÀåÀº ½ÃÀå¿¡µµ º¯È­¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. ½º¸¶Æ® ÁÖ»ç±â ¹× ¿þ¾î·¯ºí ÁÖ»ç±â´Â Åõ¾à Á¤È®µµ ¸ð´ÏÅ͸µ, Åõ¾à »óȲ ÃßÀû, Á¢Á¾·ü¿¡ ´ëÇÑ ½Ç½Ã°£ µ¥ÀÌÅÍ ¼öÁýÀÌ °¡´ÉÇÏ¿© ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥ ¹× ¹é½Å ÃßÀûÀ» °³¼±ÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºñ°­ Åõ¿© ½Ã½ºÅÛÀÇ ¹ßÀüÀ¸·Î ºñħ½ÀÀû ¹é½Å Åõ¿©ÀÇ ¼±ÅñÇÀÌ È®´ëµÇ¾î µ¶°¨ ¹é½Å°ú °°Àº ¹é½ÅÀ» º¸´Ù °£ÆíÇϰí È¿À²ÀûÀ¸·Î Åõ¿©ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ¹é½Å Àü´Þ µð¹ÙÀ̽ºÀÇ ¼º´É°ú ¾ÈÀü¼ºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó, º¸´Ù Á¢±ÙÇϱ⠽±°í, »ç¿ëÇϱ⠽±°í, Áö¼Ó°¡´ÉÇÑ ¿¹¹æÁ¢Á¾ ¼Ö·ç¼ÇÀ̶ó´Â ¼¼°è ¸ñÇ¥¿¡µµ ºÎÇÕÇÕ´Ï´Ù.

´Ù¾çÇÑ ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥¿¡¼­ ¹é½Å Àü´Þ µð¹ÙÀ̽ºÀÇ »õ·Î¿î Àû¿ë »ç·Ê´Â ¹«¾ùÀΰ¡?

¹é½Å Àü´Þ µð¹ÙÀ̽º´Â º¸´Ù È¿À²ÀûÀ̰í, Á¢±ÙÇϱ⠽±°í, ¾ÈÀüÇÑ ¿¹¹æÁ¢Á¾ ¹æ¹ýÀÇ Çʿ伺À¸·Î ÀÎÇØ ´Ù¾çÇÑ ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥¿¡ Àû¿ëÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. Á¤±âÀûÀÎ ¼Ò¾Æ ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥¿¡¼­´Â È«¿ª, µðÇÁÅ׸®¾Æ, ¼Ò¾Æ¸¶ºñ µîÀÇ Áúº´¿¡ ´ëÇÑ ¹é½ÅÀ» Åõ¿©Çϱâ À§ÇØ ÀÚµ¿ÁÖ»ç±â³ª ±ÙÀ°ÁÖ»ç±â¿Í °°Àº Àåºñ°¡ ÀϹÝÀûÀ¸·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â Á¤È®ÇÑ Åõ¿©¿Í ¾ÈÀüÇÑ Åõ¿©¸¦ º¸ÀåÇϰí, ³ôÀº ¿¹¹æÁ¢Á¾·üÀ» ´Þ¼ºÇϰí, ¹é½ÅÀ¸·Î ¿¹¹æ °¡´ÉÇÑ Áúº´À» ¿¹¹æÇϱâ À§ÇÑ Àü ¼¼°èÀÇ ³ë·ÂÀ» µ½°í ÀÖ½À´Ï´Ù. µ¶°¨, Æó·Å±¸±Õ, COVID-19 ¿¹¹æÁ¢Á¾À» Æ÷ÇÔÇÑ ¼ºÀÎ ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥¿¡¼­ ¹Ù´Ã ¾ø´Â ÁÖ»ç±â¿Í ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡´Â ƯÈ÷ ÁÖ»ç¹Ù´Ã °øÆ÷ÁõÀÌ Àִ ȯÀڵ鿡°Ô ´õ ºü¸¥ Åõ¾à, ÅëÁõ °¨¼Ò, ȯÀÚ ¼øÀÀµµ Çâ»ó µîÀÇ ÀÌÁ¡À» Á¦°øÇÔÀ¸·Î½á ¸¹Àº ÁöÁö¸¦ ¹Þ°í ÀÖ½À´Ï´Ù.

COVID-19 ÆÒµ¥¹Í°ú ½ÅÁ¾ °¨¿°º´¿¡ ´ëÀÀÇϱâ À§ÇÑ ½Å¼ÓÇÏ°í ´ë±Ô¸ð ¹é½Å Á¢Á¾ Ä·ÆäÀο¡´Â ´Ù¿ëµµ·Î È®Àå °¡´ÉÇÑ Àü´Þ ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇϸç, COVID-19 ÆÒµ¥¹Í ±â°£ Áß È¿À²ÀûÀÎ ¹é½Å Á¢Á¾À» À§ÇØ ±ÙÀ°³» ¹é½Å¿ë ÀÚµ¿ ºÐ¸®Çü ÁÖ»ç±âºÎÅÍ ºñ°­ ½ºÇÁ·¹ÀÌ¿¡ À̸£±â±îÁö ´Ù¾çÇÑ Àü´Þ Àåºñ°¡ µµÀԵǾú½À´Ï´Ù. ºñ°­ ½ºÇÁ·¹ÀÌ¿¡ À̸£±â±îÁö ´Ù¾çÇÑ Àü´Þ Àåºñ°¡ µµÀԵǾú½À´Ï´Ù. ¾ÈÁ¤¼º°ú È¿´ÉÀ» À¯ÁöÇϱâ À§ÇØ Æ¯¼öÇÑ Àü´Þ ±â¼úÀ» ÇÊ¿ä·Î ÇÏ´Â mRNA ¹é½ÅÀÇ °³¹ßµµ Ư¼ö ÁÖ»ç±â ¹× ÄݵåüÀÎ ´ëÀÀ ÀåºñÀÇ Ã¤ÅÃÀ» ÃËÁøÇß½À´Ï´Ù. ±¤°ßº´À̳ª °áÇÙ°ú °°Àº ¹é½ÅÀÇ Çdz» ÁÖ»ç±â »ç¿ëÀÌ È®´ëµÇ¸é¼­ ÀÚ¿øÀÌ Á¦ÇÑµÈ È¯°æ¿¡¼­ ¹é½Å °ø±ÞÀ» ±Ø´ëÈ­Çϱâ À§ÇØ Åõ¿©·®À» Àý¾àÇÏ´Â Àü·«À» °¡´ÉÇÏ°Ô ÇÏ´Â Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¾Ï ¹é½Å°ú HIV ¹× °£¿°°ú °°Àº ¸¸¼ºÁúȯ Ä¡·á¿ë ¹é½Åµµ Ç¥ÀûÈ­ÇÒ ¼ö ÀÖ´Â Çõ½ÅÀûÀÎ Àü´ÞÀåºñÀÇ ÇýÅÃÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î Ä¡·á¿ë ¹é½ÅÀ» ÀÏÁ¤ ±â°£ Áß ÇÇÇÏ·Î Åõ¿©ÇÏ´Â ¿þ¾î·¯ºí ÁÖ»ç±â´Â ¾Ï ¸é¿ª ¿ä¹ý¿¡¼­ À¯¸ÁÇÑ ¼Ö·ç¼ÇÀ¸·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù. ¹é½Å Àü´Þ µð¹ÙÀ̽ºÀÇ ´Ù¾ç¼º°ú ÀûÀÀ¼ºÀº ´Ù¾çÇÑ ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥¿¡¼­ È¿°úÀûÀÎ ¹é½Å Á¢Á¾·ü ´Þ¼º, ȯÀÚ °á°ú °³¼±, ¼¼°è º¸°Ç ±¸»ó Áö¿ø µî Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇϰí ÀÖ½À´Ï´Ù.

¹é½Å Àü´Þ µð¹ÙÀ̽º ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº ¹«¾ùÀΰ¡?

¹é½Å Àü´Þ µð¹ÙÀ̽º ½ÃÀåÀÇ ¼ºÀåÀº Àü ¼¼°è ¿¹¹æÁ¢Á¾ Ȱµ¿ Áõ°¡, ¹é½Å °³¹ßÀÇ ¹ßÀü, º¸´Ù ¾ÈÀüÇϰí È¿À²ÀûÀÎ Àü´Þ ¹æ¹ýÀÇ Çʿ伺 µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎ Áß Çϳª´Â Á¤±âÀûÀÎ ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥, ´ëÀ¯Çà ´ëºñ, ½ÅÁ¾ °¨¿°º´¿¡ ´ëÇÑ ´ëÀÀÀ¸·Î ÀÎÇÑ ¹é½Å ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù. °¢±¹ Á¤ºÎ¿Í ±¹Á¦±â±¸°¡ ¹é½Å Á¢Á¾·ü°ú Á¢Á¾·ü Çâ»ó¿¡ ÁýÁßÇϸ鼭 ½Å·ÚÇÒ ¼ö ÀÖ°í È®Àå °¡´ÉÇÑ Àü´Þ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡, ÀÚµ¿ ºñȰ¼ºÈ­ ÁÖ»ç±â, ¹Ù´Ã ¾ø´Â ÁÖ»ç±â µîÀÇ ±â¼ú Çõ½ÅÀº ±âÁ¸ ÁÖ»ç¹Ù´Ã »ç¿ë ¹æ½Ä°ú °ü·ÃµÈ ¹°·ù ¹®Á¦¸¦ ¿ÏÈ­ÇÏ¿© Áý´Ü ¿¹¹æÁ¢Á¾ Ä·ÆäÀο¡ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù.

COVID-19 ¹é½ÅÀÇ ±Þ¼ÓÇÑ °³¹ß ¹× ¹èÆ÷·Î ÀÎÇØ º¸´Ù ½Å¼ÓÇÑ Åõ¿©¿Í ¾ÈÀüÇϰí È¿°úÀûÀÎ ¿¹¹æÁ¢Á¾À» °¡´ÉÇÏ°Ô Çϴ ÷´Ü Àü´Þ ÀåºñÀÇ Çʿ伺ÀÌ ºÎ°¢µÇ°í ÀÖ½À´Ï´Ù. Ư¼öÇÑ Àü´Þ ±â¼úÀ» ÇÊ¿ä·Î ÇÏ´Â mRNA, DNA, ¹ÙÀÌ·¯½º º¤ÅÍ ¹é½ÅÀÌ È®´ëµÊ¿¡ µû¶ó ¹é½ÅÀÇ ¾ÈÁ¤¼ºÀ» À¯ÁöÇÏ°í ¸é¿ª ¹ÝÀÀÀ» ÃÖÀûÈ­ÇÏ´Â Çõ½ÅÀûÀÎ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ȯÀÚÀÇ ¼øÀÀµµ¸¦ ³ôÀ̰í, ÁÖ»ç¹Ù´Ã°ú °ü·ÃµÈ À§ÇèÀ» ÁÙÀ̰í, ¹Ù´ÃÀ» »ç¿ëÇÏÁö ¾Ê´Â ÃÖ¼Òħ½ÀÀû Àü´Þ ¹æ¹ý¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¼±Áø±¹°ú °³¹ßµµ»ó±¹ ¸ðµÎ¿¡¼­ »õ·Î¿î Àü´Þ ±â¼úÀÇ Ã¤ÅÃÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

Á¤ºÎ ±¸»ó, ÀÇ·á °³Çõ, ¹é½Å Á¢±Ù¼º ÇÁ·Î±×·¥ È®´ëµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ¼¼°èº¸°Ç±â±¸(WHO)¿Í À¯´Ï¼¼ÇÁ(UNICEF)´Â ¾ÈÀüÇÑ ÁÖ»ç ¹æ¹ýÀÇ »ç¿ëÀ» °­Á¶ÇÏ°í ±³Â÷ ¿À¿°À» ¹æÁöÇÏ°í ¹é½ÅÀÇ ¾ÈÀü¼ºÀ» Çâ»ó½Ã۱â À§ÇØ ÀÚµ¿ ºñȰ¼ºÈ­ ÁÖ»ç±â ¹× ±âŸ ¾ÈÀü ¼³°è ÀåºñÀÇ Ã¤ÅÃÀ» Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀçÅÃÀÇ·á ¹× ºÐ»êÇü ÀÇ·áÀÇ ºÎ»óÀ¸·Î ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡, ºñ°­ÁÖ»çÁ¦ µî ÀÚ°¡Åõ¿©Çü ¹é½Å µð¹ÙÀ̽º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© º¸´Ù À¯¿¬ÇÑ ¹é½Å Á¢Á¾ Àü·«À» Áö¿øÇϰí ÀÖ½À´Ï´Ù. µð¹ÙÀ̽º ±â¼ú, µðÁöÅÐ ÅëÇÕ, Áö¼Ó°¡´ÉÇÑ Á¦Á¶ ºÐ¾ßÀÇ Áö¼ÓÀûÀÎ Çõ½ÅÀ¸·Î ¹é½Å Àü´Þ µð¹ÙÀ̽º ½ÃÀåÀº ¹é½ÅÀÇ Á¢±Ù¼º, ¾ÈÀü¼º, È¿À²¼ºÀ» ³ôÀ̱â À§ÇÑ Àü ¼¼°èÀûÀÎ ³ë·Â¿¡ ÈûÀÔ¾î °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÎ¹®

µð¹ÙÀ̽º(ÁÖ»ç±â, Á¦Æ® ÀÎÁ§ÅÍ, ±âŸ µð¹ÙÀ̽º) ; Åõ¿©°æ·Î(±ÙÀ°Á¢Á¾, ÇÇÇÏÁ¢Á¾, Çdz»Á¢Á¾, °æÇÇÁ¢Á¾, ±âŸ Åõ¿©°æ·Î)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÁÖ¸ñ ÇÕ°è 42»ç)

  • 3M
  • Becton Dickinson & Company
  • BioJect Medical Technologies, Inc.(Inovio Pharmaceuticals, Inc.)
  • Corium International, Inc
  • Gerresheimer AG
  • Pharmajet, Inc
  • Schott AG
  • Valeritas
  • Vaxxas

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

  • ½ÃÀå °³¿ä
  • ÁÖ¿ä ±â¾÷
  • ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ
  • ¼¼°è ½ÃÀåÀÇ Àü¸Á

Á¦3Àå ½ÃÀå ºÐ¼®

  • ¹Ì±¹
  • ij³ª´Ù
  • ÀϺ»
  • Áß±¹
  • À¯·´
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ¿µ±¹
  • ½ºÆäÀÎ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • È£ÁÖ
  • Àεµ
  • Çѱ¹
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ¸ß½ÃÄÚ
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
  • À̶õ
  • À̽º¶ó¿¤
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦4Àå °æÀï

KSA 25.03.07

Global Vaccine Delivery Devices Market to Reach US$6.6 Billion by 2030

The global market for Vaccine Delivery Devices estimated at US$5.1 Billion in the year 2024, is expected to reach US$6.6 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Syringes, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$5.3 Billion by the end of the analysis period. Growth in the Jet Injectors segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 7.5% CAGR

The Vaccine Delivery Devices market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 7.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Vaccine Delivery Devices Market - Key Trends & Drivers Summarized

What Are Vaccine Delivery Devices, and Why Are They So Crucial in Modern Immunization?

Vaccine Delivery Devices are specialized tools and technologies designed to administer vaccines safely, effectively, and accurately. These devices include syringes, needle-free injectors, microneedle patches, nasal sprays, intradermal injectors, and oral delivery devices. They are used to deliver various types of vaccines, including inactivated, live-attenuated, mRNA, subunit, and viral vector vaccines, ensuring the vaccines reach the appropriate tissue for optimal immune response. These devices not only improve the efficiency and accuracy of vaccine administration but also enhance patient compliance, reduce the risk of needle-stick injuries, and minimize wastage.

The importance of vaccine delivery devices lies in their ability to support successful immunization programs by ensuring safe and effective vaccine administration. Efficient vaccine delivery is critical for achieving high immunization coverage, especially in mass vaccination campaigns and public health initiatives aimed at controlling infectious diseases. Devices like auto-disable syringes help prevent reuse and reduce infection risks, while needle-free injectors improve vaccine acceptance among needle-phobic populations. As global vaccination needs grow, particularly in response to pandemics, routine immunization, and emerging infectious diseases, vaccine delivery devices have become essential components of healthcare infrastructure, supporting timely and effective immunization efforts.

How Are Technological Advancements Shaping the Vaccine Delivery Devices Market?

Technological advancements have significantly improved the design, safety, and efficiency of Vaccine Delivery Devices, driving innovation across immunization programs worldwide. One of the major developments is the introduction of microneedle patches, which offer a painless, minimally invasive way to deliver vaccines intradermally. Microneedle patches are coated or filled with vaccines and can be self-administered, making them ideal for mass vaccination campaigns, remote locations, and low-resource settings. These patches do not require refrigeration, reducing cold chain logistics and facilitating broader access to vaccines, especially in developing countries.

Another key advancement is in the development of needle-free injectors, which use high-pressure streams to deliver vaccines through the skin without the use of needles. These devices reduce the risk of needle-stick injuries, improve patient compliance, and minimize biohazard waste. Needle-free injectors have been used in administering vaccines for diseases like influenza, measles, and hepatitis, and are being adapted for emerging vaccines, including those for COVID-19 and tuberculosis. In addition to needle-free systems, innovations in auto-disable syringes have improved safety during immunization. These syringes are designed to lock automatically after a single use, preventing reuse and reducing the risk of cross-contamination, making them crucial for safe vaccine administration, especially in mass campaigns.

The rise of smart delivery devices that integrate digital technology is transforming the market as well. Smart syringes and wearable injectors can monitor dosing accuracy, track administration, and collect real-time data on vaccination coverage, helping healthcare providers improve immunization programs and vaccine tracking. Advances in intranasal delivery systems have also expanded the options for non-invasive vaccine administration, offering easy and efficient delivery of vaccines such as the flu vaccine. These technological innovations are not only improving the performance and safety of vaccine delivery devices but also aligning with global goals for more accessible, user-friendly, and sustainable immunization solutions.

What Are the Emerging Applications of Vaccine Delivery Devices Across Different Immunization Programs?

Vaccine Delivery Devices are finding expanding applications across a wide range of immunization programs, driven by the need for more efficient, accessible, and safer vaccination methods. In routine childhood immunization programs, devices like auto-disable syringes and intramuscular injectors are commonly used to deliver vaccines for diseases such as measles, diphtheria, and polio. These devices ensure precise dosing and safe administration, supporting global efforts to achieve high immunization coverage and prevent vaccine-preventable diseases. In adult immunization programs, including influenza, pneumococcal, and COVID-19 vaccinations, needle-free injectors and microneedle patches are gaining traction as they offer faster administration, reduced pain, and improved patient compliance, particularly among needle-phobic individuals.

In response to pandemics and emerging infectious diseases, rapid and large-scale vaccination campaigns require versatile and scalable delivery solutions. During the COVID-19 pandemic, a variety of delivery devices were deployed to ensure efficient vaccine rollout, from auto-disable syringes for intramuscular vaccines to intranasal sprays for easier administration. The development of mRNA vaccines, which require specific delivery techniques to maintain stability and efficacy, has also driven the adoption of specialized injectors and cold-chain-compatible devices. The expanding use of intradermal injectors for vaccines like rabies and tuberculosis highlights the growing demand for devices that allow for dose-sparing strategies, maximizing vaccine supply in resource-limited settings.

Therapeutic vaccines, such as cancer vaccines and those for chronic diseases like HIV and hepatitis, also benefit from innovative delivery devices that provide targeted administration. For example, wearable injectors that deliver therapeutic vaccines subcutaneously over a controlled period have emerged as a promising solution in cancer immunotherapy. The versatility and adaptability of vaccine delivery devices across these diverse immunization programs reflect their critical role in achieving effective vaccination coverage, improving patient outcomes, and supporting global health initiatives.

What Drives Growth in the Vaccine Delivery Devices Market?

The growth in the Vaccine Delivery Devices market is driven by several factors, including increasing global immunization efforts, advancements in vaccine development, and the need for safer and more efficient delivery methods. One of the primary growth drivers is the rising demand for vaccines, fueled by routine immunization programs, pandemic preparedness, and efforts to address emerging infectious diseases. As governments and international organizations focus on improving vaccination rates and coverage, the demand for reliable, scalable delivery devices has surged. Innovations such as microneedle patches, auto-disable syringes, and needle-free injectors have supported mass vaccination campaigns, reducing the logistical challenges associated with traditional needle-based methods.

The rapid development and deployment of COVID-19 vaccines highlighted the critical need for advanced delivery devices that can facilitate faster administration and ensure safe, effective immunization. The expansion of mRNA, DNA, and viral vector vaccines, which often require specialized delivery techniques, has further driven demand for innovative devices that maintain vaccine stability and optimize immune response. The increasing focus on needle-free and minimally invasive delivery methods, which improve patient compliance and reduce needle-associated risks, has accelerated the adoption of new delivery technologies in both developed and developing regions.

Government initiatives, healthcare reforms, and expanded vaccine access programs have also contributed to market growth. For example, the World Health Organization (WHO) and UNICEF have emphasized the use of safe injection practices, promoting the adoption of auto-disable syringes and other safety-engineered devices to prevent cross-contamination and improve vaccine safety. Additionally, the rise of home-based and decentralized healthcare services has increased demand for self-administrable vaccine devices, such as microneedle patches and nasal sprays, supporting more flexible vaccination strategies. With ongoing innovations in device technology, digital integration, and sustainable manufacturing, the Vaccine Delivery Devices market is poised for robust growth, driven by global efforts to enhance vaccine accessibility, safety, and efficiency.

SCOPE OF STUDY:

The report analyzes the Vaccine Delivery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device (Syringes, Jet Injectors, Other Devices); Route of Administration (Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination, Other Route of Administrations)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • 3M
  • Becton Dickinson & Company
  • BioJect Medical Technologies, Inc. (Inovio Pharmaceuticals, Inc.)
  • Corium International, Inc
  • Gerresheimer AG
  • Pharmajet, Inc
  • Schott AG
  • Valeritas
  • Vaxxas

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Vaccine Delivery Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Vaccine Administration Drives Demand for Vaccine Delivery Devices
    • Advancements in Needle-Free Injection Systems Propel Vaccine Delivery Device Market
    • Expanding Role of Self-Administered Vaccines Sets the Stage for Device Adoption
    • Case Overview: Demand for Single-Use Syringes Enhances Vaccine Delivery Device Market
    • Innovations in Microneedle Technology Generate New Opportunities for Vaccine Devices
    • Focus on Reducing Vaccine Wastage Bodes Well for Delivery Device Adoption
    • Growing Use of Auto-Disable Syringes Sustains Vaccine Delivery Device Market
    • Expanding Role of Prefilled Syringes Enhances Vaccine Delivery Market Growth
    • Push for Improved Immunization Programs Drives Vaccine Delivery Device Adoption
    • Case Overview: Innovations in Smart Syringes Propel Vaccine Delivery Devices
    • Innovations in Intradermal Delivery Propel Vaccine Delivery Device Growth
    • Focus on Mass Immunization Programs Bodes Well for Vaccine Delivery Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Vaccine Delivery Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Vaccine Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Vaccine Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Jet Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Intramuscular Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Intramuscular Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Intramuscular Vaccination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Subcutaneous Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Subcutaneous Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Subcutaneous Vaccination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Intradermal Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Intradermal Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Intradermal Vaccination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Route of Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Route of Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Route of Administrations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • JAPAN
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • CHINA
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • EUROPE
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Vaccine Delivery Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Vaccine Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • FRANCE
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • GERMANY
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Vaccine Delivery Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Vaccine Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • INDIA
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Vaccine Delivery Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Vaccine Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Vaccine Delivery Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Vaccine Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • AFRICA
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030

IV. COMPETITION

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦